Netarsudil as an Add-On Therapy for Glaucoma Patients Who Are Already on Maximally Tolerated Topical Medical Therapy (Code-T0333) [Internet]. Medical Thesis; 2025 [cited 2025 Jun. 7]. Available from: https://medicalthesis.org/index.php/mt/catalog/book/339